Cancer and mTOR inhibitors in kidney transplantation recipients

BACKGROUND: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. METHODS: In the current study, patients were registered in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PeerJ
Hauptverfasser: Kao, Chih-Chin, Liu, Jia-Sin, Chang, Yu-Kang, Lin, Ming-Huang, Lin, Yen-Chung, Chen, Hsi-Hsien, Chang, Wei-Chiao, Hsu, Chih-Cheng, Wu, Mai-Szu
Format: Artigo
Sprache:Inglês
Veröffentlicht: PeerJ Inc. 2018
Schlagworte:
Internal Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237112/
https://ncbi.nlm.nih.gov/pubmed/30473931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.5864
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge